英国医院获得性肺炎管理指南：英国抗菌化疗协会医院获得性肺炎工作组报告
Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.
作者信息
Masterton R G, Galloway A, French G, Street M, Armstrong J, Brown E, Cleverley J, Dilworth P, Fry C, Gascoigne A D, Knox Alan, Nathwani Dilip, Spencer Robert, Wilcox Mark
机构信息
Department of Microbiology, Crosshouse Hospital, Kilmarnock, UK.
出版信息
J Antimicrob Chemother. 2008 Jul;62(1):5-34. doi: 10.1093/jac/dkn162. Epub 2008 Apr 29.
Abstract
These evidence-based guidelines have been produced after a systematic literature review of a range of issues involving prevention, diagnosis and treatment of hospital-acquired pneumonia (HAP). Prevention is structured into sections addressing general issues, equipment, patient procedures and the environment, whereas in treatment, the structure addresses the use of antimicrobials in prevention and treatment, adjunctive therapies and the application of clinical protocols. The sections dealing with diagnosis are presented against the clinical, radiological and microbiological diagnosis of HAP. Recommendations are also made upon the role of invasive sampling and quantitative microbiology of respiratory secretions in directing antibiotic therapy in HAP/ventilator-associated pneumonia.
摘要
这些循证指南是在对一系列涉及医院获得性肺炎（HAP）预防、诊断和治疗问题的文献进行系统综述后制定的。预防部分分为针对一般问题、设备、患者操作和环境等方面，而治疗部分则涉及抗菌药物在预防和治疗中的使用、辅助治疗以及临床方案的应用。关于诊断的部分是针对HAP的临床、影像学和微生物学诊断呈现的。还就侵入性采样和呼吸道分泌物定量微生物学在指导HAP/呼吸机相关性肺炎抗生素治疗中的作用提出了建议。
相似文献
1
Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy.
J Antimicrob Chemother. 2008 Jul;62(1):5-34. doi: 10.1093/jac/dkn162. Epub 2008 Apr 29.
2
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials.
Crit Care. 2017 Jun 27;21(1):162. doi: 10.1186/s13054-017-1755-5.
3
The methodological quality of guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia: A systematic review.
J Clin Pharm Ther. 2018 Aug;43(4):450-459. doi: 10.1111/jcpt.12696. Epub 2018 May 2.
4
Interventions to improve antibiotic prescribing practices for hospital inpatients.
Cochrane Database Syst Rev. 2017 Feb 9;2(2):CD003543. doi: 10.1002/14651858.CD003543.pub4.
5
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
6
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
7
NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements. 2002;19(3):1-46.
8
The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation.
Health Technol Assess. 2008 Apr;12(12):iii-iv, xi-xii, 1-154. doi: 10.3310/hta12120.
9
The measurement and monitoring of surgical adverse events.
Health Technol Assess. 2001;5(22):1-194. doi: 10.3310/hta5220.
10
Chest physiotherapy for pneumonia in adults.
Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD006338. doi: 10.1002/14651858.CD006338.pub4.
引用本文的文献
1
Biomarkers for pneumonia after major trauma: A systematic review and meta-analysis.
J Intensive Care Soc. 2025 Jun 13:17511437251344068. doi: 10.1177/17511437251344068.
2
D-PRISM: a global survey-based study to assess diagnostic and treatment approaches in pneumonia managed in intensive care.
Crit Care. 2024 Nov 22;28(1):381. doi: 10.1186/s13054-024-05180-y.
3
Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges.
Nat Commun. 2024 Jul 31;15(1):6447. doi: 10.1038/s41467-024-50805-z.
4
Definitions of hospital-acquired pneumonia in trauma research: a systematic review.
Eur J Trauma Emerg Surg. 2024 Oct;50(5):2005-2015. doi: 10.1007/s00068-024-02509-8. Epub 2024 Mar 28.
5
Association between nurse staffing level in intensive care settings and hospital-acquired pneumonia among surgery patients: result from the Korea National Health Insurance cohort.
Epidemiol Infect. 2024 Feb 8;152:e62. doi: 10.1017/S0950268824000232.
6
Clinical Characteristics and Prognosis of Hospital-Acquired Bacteremic Pneumonia versus Bacteremic Pneumonia: A Retrospective Comparative Study.
Infect Drug Resist. 2023 Aug 2;16:4977-4994. doi: 10.2147/IDR.S419699. eCollection 2023.
7
Respiratory Infections in the Aging Lung: Implications for Diagnosis, Therapy, and Prevention.
Aging Dis. 2023 Aug 1;14(4):1091-1104. doi: 10.14336/AD.2023.0329.
8
Clinical value of serum sTREM-1 and HBP levels in combination with traditional inflammatory markers in diagnosing hospital-acquired pneumonia in elderly.
BMC Infect Dis. 2022 Oct 4;22(1):773. doi: 10.1186/s12879-022-07758-9.
9
[Update of the recommendations of the Pneumonia Zero project].
Enferm Intensiva. 2022 Sep;33:S17-S30. doi: 10.1016/j.enfi.2022.05.005. Epub 2022 Jul 27.
10
Host Defence Peptides: A Potent Alternative to Combat Antimicrobial Resistance in the Era of the COVID-19 Pandemic.
Antibiotics (Basel). 2022 Apr 1;11(4):475. doi: 10.3390/antibiotics11040475.
本文引用的文献
1
Prospective, randomized comparison of intravenous and oral ciprofloxacin with intravenous ceftazidime in the treatment of nosocomial pneumonia.
Can J Infect Dis. 1997 Mar;8(2):89-94. doi: 10.1155/1997/973029.
2
The place of guidelines in hospital-acquired pneumonia.
J Hosp Infect. 2007 Jun;66(2):116-22. doi: 10.1016/j.jhin.2007.03.008. Epub 2007 May 7.
3
Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK.
J Antimicrob Chemother. 2006 Apr;57(4):589-608. doi: 10.1093/jac/dkl017. Epub 2006 Feb 28.
4
Adherence to simple and effective measures reduces the incidence of ventilator-associated pneumonia.
Can J Anaesth. 2005 May;52(5):535-41. doi: 10.1007/BF03016535.
5
Antibiotic prophylaxis of early onset pneumonia in critically ill comatose patients. A randomized study.
Intensive Care Med. 2005 Apr;31(4):510-6. doi: 10.1007/s00134-005-2585-5. Epub 2005 Mar 8.
6
Surveillance of hospital water and primary prevention of nosocomial legionellosis: what is the evidence?
J Hosp Infect. 2005 Apr;59(4):273-9. doi: 10.1016/j.jhin.2004.09.031.
7
A randomized, placebo-controlled study of the use of filgrastim in non neutropenic patients with nosocomial pneumonia.
Eur J Med Res. 2005 Jan 28;10(1):29-35.
8
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.
Am J Respir Crit Care Med. 2005 Feb 15;171(4):388-416. doi: 10.1164/rccm.200405-644ST.
9
Ventilator-associated pneumonia using a closed versus an open tracheal suction system.
Crit Care Med. 2005 Jan;33(1):115-9. doi: 10.1097/01.ccm.0000150267.40396.90.
10
Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis.
Am J Med. 2005 Jan;118(1):11-8. doi: 10.1016/j.amjmed.2004.07.051.
Zotero 插件